CUBEBIO’s cancer self-diagnostic device is capable of detecting 8 major cancer types (breast cancer, colorectal cancer, stomach cancer, liver cancer, lung cancer, pancreatic cancer, prostate cancer, and bladder cancer) at an early stage by using urine as a specimen.
As you start the device, you will be able to see ‘Test,’ ‘Instruction,’ ‘Administrator,’ ‘Illness History,’ ‘Summary,’ and ‘Setting’ on a screen. First, you put urine on a sensor. Next, you place it on a tray and insert it into an analyzer. Then, you press the ‘Test’ button with a light touch.
In about 15 minutes, you can do whatever you want, whether it be drinking a cup of coffee, taking a shower, or working, in a variety of settings, including home, hospital, pharmacy, coffee shop, office, convenience store, and bank. Finally, you check the diagnostic result on the screen, save it in your medical history, and monitor your health status on a frequent basis.
※ This video will be promoted worldwide in the first half of this year.
CUBEBIO’s Multi-Channel Automatic diagnostic devices, ‘CMDD Series’
In response to successive demands from overseas customers for the development of automated diagnostic systems, we incorporated FPA, a company specialized in manufacturing automated equipment, as a wholly-owned subsidiary and developed our first Multi-Channel Automatic diagnostic devices, 'CMDD Series'.
CMDD Series can diagnose 8 cancer types (Breast cancer, Colorectal cancer, Lung cancer, Liver cancer, Stomach cancer, Pancreatic cancer, Prostate cancer, and Bladder cancer) with the use of urine as a specimen.
The series include the following products:
● CMDD-20’ – Diagnoses 20 people at once and suitable to be used in large hospitals and examination centers.
● ‘CMDD-12’ - Diagnoses 12 people at once and suitable to be used in small & medium-sized hospitals and clinics.
● ‘CMDD-04’ - Diagnoses 4 people at once and suitable to be used in offices, pharmacies and at home.
CUBEBIO receives 'TI-3' rating for investment-type technology assessment, TCB (Technology Credit Bureau)
Obtaining ISO 13485:2016 certification for additional production facility
Close for 1day
Close
Innovation in Cancer Diagnosis
The world’s first total solution cancer care companyRecent News
View More